Burden of Diabetes in Australia: It's Time for More Action Report

Working with Sydney University and Western Sydney University, Novo Nordisk has launched the Burden of Diabetes in Australia: It's Time for More Action report revealing that diabetes care is falling short for many Australians. 

Find out more here 

Burden of Diabetes in Australia Report

Product Information

Written principally for Healthcare Professionals, the Product Information documents provide prescribing information for each of our products. To access the documents click here

Modern Slavery Statement

Click here to read more about the Novo Nordisk Modern Slavery statement.

Coronavirus

Our updates during the COVID-19 pandemic

During the COVID-19 pandemic our key priority is to safeguard the continued supply of our medicines to people living with diabetes and other serious chronic diseases. Currently, we are not expriencing any supply constraints.

We strongly encourage people to purchase their medicine as normal. We are well prepared for situations like this and we have a storage policy that ensures long-term supply.  In Australia and New Zealand we are in close contact with our wholesalers, distributors and pharmacies to monitor the availability of our medicine.

Everyday, new questions and concerns are being raised and we want to keep you informed with updates on the supply of our medicine. If you have questions or concerns our NovoCare Customer Care Centre is available everyday on 1800 668 626 (freecall) or 0800 733 737 (New Zealand), by email at: aunrccc@novonordisk.com

As we continue to monitor the situation, we will share our updates here.

Last updated 16 April 2020

We offer 0 job opportunities

For jobs in the United States, please visit our US career site.

Structured approach to ethical business

Each day, Novo Nordisk employees bring ethical standards to work. 
Click here to read more

Medicines Australia Transparency Reports

Please click here to access the reports

Report a complaint or side effect

Your information about complaints and side effects helps us ensure the safety of our products. 
How to report a complaint or side effect 

Contact Us

Novo Nordisk Pharmaceuticals Pty Ltd
PO Box 7586
Baulkham Hills BC NSW 2153
Australia
ABN 40 002 879 996
Tel: 1800 224 321
Fax: +61 2 8858 3799

Media Enquiries:
Jodie Thomas
Director - Government Relations & Market Access
Tel: +61 0408 200 523
E: jdth@novonordisk.com
HQ Media Relations Contacts

Privacy Officer:
privacyofficeroceania@
novonordisk.com
 

NovoCare® Customer Care Centre:
Tel:
 1800 668 626
Fax: +61 2 8858 3799

NordiCare® Hotline:
Tel:
 1800 632 362
Fax: +61 2 8858 3799

Orders:
Wholesaler Orders - email
Norditropin® Orders - email
Novoseven®RT Orders:
     NBA - email
     Non NBA - email